As private company CEOs review the provisions of the federal Patient Protection and Affordable Care Act (the “Act”), nearly half (47%) of executives surveyed for PwC‘s Private Company Trendsetter Barometer say the Act may have a notable financial impact on their business. However, nearly one-third (31%) of respondents believe it’s “too soon to tell” how the Act’s provisions will impact their companies. Twenty percent don’t anticipate a notable financial impact; 2% were unreported. Companies that don’t anticipate a notable financial impact are forecasting above-average revenue growth, compared with the other companies surveyed.
Although the majority of Trendsetter CEOs (70%) have begun reviewing their healthcare benefit plans in light of the Act, 55% have not yet determined what changes need to be made to their companies’ plans. Only 15% have started to take action.
“In helping our clients assess the effect that healthcare reform will have on their organizations, we’ve been looking at their overall healthcare benefit packages to evaluate whether they’re in compliance with the Act, as well as considering strategies for managing the expected increase in healthcare costs,” says Ken Esch, a partner in PwC’s Private Company Services practice. “In light of current economic conditions, it’s imperative that companies begin assessing their healthcare plans and cost-containment strategies soon rather than later.”